Open AccessConcizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient’s Perspectives
Author(s) -
Samantha Pasca
Publication year - 2022
Publication title -
journal of blood medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.676
H-Index - 18
ISSN - 1179-2736
DOI - 10.2147/jbm.s242219
Subject(s) - medicine , tissue factor pathway inhibitor , anticipation (artificial intelligence) , clinical trial , thrombin generation , monoclonal antibody , intensive care medicine , in vivo , bioinformatics , antibody , immunology , tissue factor , coagulation , pathology , thrombin , platelet , microbiology and biotechnology , artificial intelligence , biology , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom